Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Head and Neck Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 141 articles: HTML format

Single Articles

May 2026
1. POON I, Karam I, Chin L, Galapin M, et al
   Implementation of Stereotactic Body Radiation Therapy SBRT for primary Primary Head and Neck Cancer.
   Int J Radiat Oncol Biol Phys. 2026;125:56-63.
   PubMed    
   
   
   April 2026
2. LUKENS JN, Riina MD, Weinstein G, MacDuffie E, et al
   Long-Term Results of a Phase II Clinical Trial of Radiation Volume and Dose De-intensification Following Transoral Robotic Surgery and Neck Dissection for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
   Int J Radiat Oncol Biol Phys. 2026 Apr 16:S0360-3016(26)00590.
   PubMed     Abstract available
   
   
   
3. SUN S, Huang X, Liu Y, Yu Z, et al
   Childhood Nasopharyngeal Carcinoma: A Rare Disease with Distinct Features and Favorable Prognosis.
   Int J Radiat Oncol Biol Phys. 2026 Apr 14:S0360-3016(26)00567.
   PubMed     Abstract available
   
   
   March 2026
4. XIE C, Shen Y, He J, Guo M, et al
   Pretreatment Radiation Esophagitis Prediction using Quantum Machine Learning in Esophageal Cancer Patients.
   Int J Radiat Oncol Biol Phys. 2026 Mar 16:S0360-3016(26)00494.
   PubMed     Abstract available
   
   
   
5. HAN JE, Diplas BH, Paudyal R, Oh JH, et al
   Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human Papillomavirus-Associated Oropharyngeal Cancer.
   Int J Radiat Oncol Biol Phys. 2026;124:1015-1023.
   PubMed     Abstract available
   
   
   
6. JI P, Shen J, He D, Chen L, et al
   Combined Real-time Liquid Biopsy with TNM Stage to Guide Induction Chemotherapy Cycles in Nasopharyngeal Carcinoma: A Development and Validation Study.
   Int J Radiat Oncol Biol Phys. 2026 Mar 12:S0360-3016(26)00493.
   PubMed     Abstract available
   
   
   
7. KIM JK, Tam M, Kim SG, Solomon E, et al
   A Phase 2 Exploratory Trial Evaluating Computed Tomography-Based Midtreatment Nodal Response to Select for De-escalated Chemoradiation Therapy in the Definitive Management of p16+ Oropharyngeal Cancer.
   Int J Radiat Oncol Biol Phys. 2026;124:662-675.
   PubMed     Abstract available
   
   
   
8. CHEN L, Cohen M, Hatzglou V, Zhang Z, et al
   Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study).
   Int J Radiat Oncol Biol Phys. 2026;124:676-685.
   PubMed     Abstract available
   
   
   February 2026
9. BENTZEN SM, Gupta T, Jacinto AA, Rosenblatt E, et al
   Hypofractionated Versus Normofractionated Accelerated Radiation Therapy With or Without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO): A Randomized, Open-Label, Phase 3, Noninferiority Trial.
   Int J Radiat Oncol Biol Phys. 2026 Feb 18:S0360-3016(26)00020.
   PubMed     Abstract available
   
   
   
10. YANG Y, Jiang Y, Wang C, Li J, et al
    Randomized Study on Different Radiation Doses in Neoadjuvant Chemoradiotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma (Neo-DRATEC Trial).
    Int J Radiat Oncol Biol Phys. 2026 Feb 17:S0360-3016(26)00390.
    PubMed     Abstract available
    
    
    
11. CUBERO L, Acosta O, Pascau J, Palard-Novello X, et al
    Voxel-based analysis identifies new functional subregions predictive of xerostomia after head and neck cancer radiotherapy.
    Int J Radiat Oncol Biol Phys. 2026 Feb 16:S0360-3016(26)00374.
    PubMed     Abstract available
    
    
    
12. RAAIJMAKERS KTPM, Peters RHW, Beekmans M, Beerkens APM, et al
    Head and Neck Squamous Cell Carcinoma patient-derived Cancer-Associated Fibroblasts undergo senescence while retaining pro-tumorigenic properties after ex vivo irradiation.
    Int J Radiat Oncol Biol Phys. 2026 Feb 14:S0360-3016(26)00395.
    PubMed     Abstract available
    
    
    
13. LEHRER EJ, Geyer S, Goodrich A, Haydu LE, et al
    The Impact of Lung and Heart Radiation Dose during Preoperative Chemoradiation on Overall Survival in Esophageal Cancer - A Post Hoc Analysis of CALGB 80803 (Alliance).
    Int J Radiat Oncol Biol Phys. 2026 Feb 5:S0360-3016(26)00362.
    PubMed     Abstract available
    
    
    
14. GAU M, Su J, Huang SH, Alfaraj FA, et al
    Nomogram for Risk-Adaptive Estimation of the Locoregional Control Benefit Following Postoperative Radiation Therapy for Pathologic N0 Oral Cavity Cancer: A Retrospective Analysis.
    Int J Radiat Oncol Biol Phys. 2026;124:328-339.
    PubMed     Abstract available
    
    
    
15. SAID BI, Boukhaled GM, Lok BH, Lukovic J, et al
    Cross-Cancer Analysis Reveals a Distinct Pattern of Immune Modulation During Curative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2026;124:441-450.
    PubMed     Abstract available
    
    
    
16. CORRY J, Ng WT, Moore A, Choi HCW, et al
    Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low and Middle-Income Countries-Reporting the Technical Component of the Second Phase of a Prospective International Atomic Energy Agency study (E33039).
    Int J Radiat Oncol Biol Phys. 2026;124:311-319.
    PubMed     Abstract available
    
    
    
17. MCDOWELL L, Corry J, Fua T, Coleman A, et al
    Prospective Evaluation of Patient Priorities in Human Papillomavirus-Driven Oropharyngeal Cancer Using the Chicago Priorities Scale: Considerations for Future Clinical Trial Design.
    Int J Radiat Oncol Biol Phys. 2026;124:320-327.
    PubMed     Abstract available
    
    
    January 2026
18. SO J, Droznin A, Tiwari P, Chen YH, et al
    Stereotactic Body Radiation Therapy With Pembrolizumab in PD-1 Inhibitor Refractory, Recurrent or Metastatic, Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2026 Jan 9:S0360-3016(26)00004.
    PubMed     Abstract available
    
    
    
19. MILLER ED, Ashman JB, Barry A, Jethwa KR, et al
    Gaining New Ground: The Evolving Role of Radiation Therapy in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2026 Jan 9:S0360-3016(26)00005.
    PubMed     Abstract available
    
    
    
20. BEDDOK A, Morvan JB, Boudin L, Da Silva Ribeiro Mota A, et al
    The Role of External Beam Radiation Therapy in Thyroid Cancer Management: A Scoping Review.
    Int J Radiat Oncol Biol Phys. 2026;124:70-91.
    PubMed     Abstract available
    
    
    
21. WANG K, Sabouri P, Wolfe A, Siegel E, et al
    Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience.
    Int J Radiat Oncol Biol Phys. 2026;124:147-158.
    PubMed     Abstract available
    
    
    December 2025
22. HUISKES M, Astreinidou E, de Jong M, den Haan N, et al
    Qualitative Blinded Clinical Assessment of Automated and Manual IMPT Plans for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Dec 19:S0360-3016(25)06503.
    PubMed     Abstract available
    
    
    
23. SASIDHARAN BK, Sidhique SK, Wilson JV, Mathew M, et al
    Pragmatic Patient Choice-Driven Radical Treatment Approach (PRAGRAD) for Very Advanced Unresectable Oral Cavity Cancers.
    Int J Radiat Oncol Biol Phys. 2025;123:1323-1334.
    PubMed     Abstract available
    
    
    November 2025
24. GUAN C, Lu T, Zhan C, Deng S, et al
    Effects of Nutritional Interventions on Quality of Life in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy Based on Dynamic Nutritional Risk Screening and Assessment: An Open-label Single-center Randomized Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2025 Nov 29:S0360-3016(25)06536.
    PubMed     Abstract available
    
    
    
25. LIN Y, Pelkmans J, Epari A, Spikes T, et al
    Associations of Biological Aging with Perceived Stress in Patients with Head and Neck Cancer Undergoing Intensity-Modulated Radiotherapy: A Longitudinal Study.
    Int J Radiat Oncol Biol Phys. 2025 Nov 22:S0360-3016(25)06497.
    PubMed     Abstract available
    
    
    
26. OBERTOPP N, Bekker RA, Grass GD, Zelenka T, et al
    Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes.
    Int J Radiat Oncol Biol Phys. 2025;123:1102-1115.
    PubMed     Abstract available
    
    
    
27. GEBRE-MEDHIN M, Adrian G, Engstrom P, Cange HH, et al
    Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III Trial.
    Int J Radiat Oncol Biol Phys. 2025;123:681-690.
    PubMed     Abstract available
    
    
    
28. MOON DH, Avkshtol V, Hughes RS, Ahn C, et al
    HYHOPE: A Phase 1 Study of Deintensified Hypofractionated Radiation Therapy for Human Papillomavirus-Associated Oropharynx Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:694-702.
    PubMed     Abstract available
    
    
    October 2025
29. SHAH KD, Chamseddine I, Yuan X, Tian S, et al
    Clinically Interpretable Survival Risk Stratification in Head and Neck Cancer Using Bayesian Networks and Markov Blankets.
    Int J Radiat Oncol Biol Phys. 2025 Oct 11:S0360-3016(25)06336.
    PubMed     Abstract available
    
    
    
30. TANDON S, Ahlawat P, Mahajan S, Bellige A, et al
    Depth of Invasion as an Independent Indication for Postoperative Radiation Therapy in Oral Tongue Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025;123:442-451.
    PubMed     Abstract available
    
    
    September 2025
31. CHEN X, Zhang S, Gou X, Dai J, et al
    Tumor Treatment Response Guided Adaptive Dose De-escalation/Escalation Strategy for Concurrent Chemoradiotherapy of Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025 Sep 26:S0360-3016(25)06314.
    PubMed     Abstract available
    
    
    
32. FAN C, Lee J, Stock S, Woody NM, et al
    Imaging Extranodal Extension (iENE) Predicts Higher Rates of Distant Recurrence for Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:120-128.
    PubMed     Abstract available
    
    
    August 2025
33. ADRIAN G, Falklind NR, McDowell L, Gebre-Medhin M, et al
    Chemoradiotherapy vs Radiotherapy Alone in T1-2 Oropharyngeal Cancer with Low Volume Neck Disease: A Population-Based Cohort Study Utilizing the XXXXX Head and Neck Cancer Register.
    Int J Radiat Oncol Biol Phys. 2025 Aug 21:S0360-3016(25)06188.
    PubMed     Abstract available
    
    
    
34. RUNGE CL, Lyness JA, Gillison ML, Adelstein DJ, et al
    Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxx.
    Int J Radiat Oncol Biol Phys. 2025 Aug 17:S0360-3016(25)06157.
    PubMed     Abstract available
    
    
    July 2025
35. LANGER CJ, Harris J, Horwitz EM, Kies M, et al
    Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination with Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): Long-term follow-up of NRG Oncology Radiation Therapy Oncolog
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06032.
    PubMed     Abstract available
    
    
    
36. RAITANO A, Kilby W, Morrison K, Capo L, et al
    Exploratory rat toxicology and efficacy of the boron neutron capture therapy drug boronotyrosine in a mouse model of head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 28:S0360-3016(25)06030.
    PubMed     Abstract available
    
    
    
37. MAURY P, Sayous Y, Marnaoui R, Loiseau C, et al
    Stereotactic Ablative Radiotherapy (SABR) Quality and Survival of Patients with Head and Neck Cancer: a post-hoc analysis of the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2025 Jul 24:S0360-3016(25)06019.
    PubMed     Abstract available
    
    
    
38. JAINAR CJE, Jacomina LE, Dee EC, Lee A, et al
    Global Disparities in Current Clinical Trials in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025 Jul 2:S0360-3016(25)04511.
    PubMed     Abstract available
    
    
    June 2025
39. JIANG M, Li H, Chen C, Li Y, et al
    Post-Irradiation Otitis Media with Effusion in Nasopharyngeal Carcinoma: A Comprehensive Review of Pathogenesis, Management, and Prevention.
    Int J Radiat Oncol Biol Phys. 2025 Jun 27:S0360-3016(25)04517.
    PubMed     Abstract available
    
    
    
40. YILMAZ MT, Cengiz M, Kahvecioglu A, Yigit E, et al
    Fifteen Years of Experience with Stereotactic Body Radiotherapy for Recurrent Head and Neck Cancers: A Detailed Analysis of Patients with Carotid Blowout Syndrome.
    Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04486.
    PubMed     Abstract available
    
    
    
41. GALLOWAY TJ, Pugh SL, Ridge JA, Nguyen-Tan PF, et al
    Long term feeding tube use in head and neck cancer survivors - a secondary analysis of patient and treatment related factors.
    Int J Radiat Oncol Biol Phys. 2025 Jun 3:S0360-3016(25)00527.
    PubMed     Abstract available
    
    
    
42. KISER KJ, Apicelli AJ, Brenneman RJ, Contreras JA, et al
    Contralateral Neck Recurrence Rates After Ipsilateral Neck Adjuvant Radiation in Head and Neck Carcinomas with a Pathologically Negative Contralateral Neck.
    Int J Radiat Oncol Biol Phys. 2025 Jun 2:S0360-3016(25)00552.
    PubMed    
    
    
    
43. MCDOWELL L, Gough K, Fua T, Coleman A, et al
    Final Results From a Longitudinal Observation Study Evaluating Sexual Health and Facial Appearance and Distress in Human Papillomavirus-Associated Oropharyngeal Cancer Survivors Treated With Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2025;122:355-364.
    PubMed     Abstract available
    
    
    
44. MORENO AC, Watson EE, Humbert-Vidan L, Peterson DE, et al
    International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study.
    Int J Radiat Oncol Biol Phys. 2025;122:341-354.
    PubMed     Abstract available
    
    
    
45. FREDERIKS ML, van Etten B, Kelder W, Dieters M, et al
    Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:313-324.
    PubMed     Abstract available
    
    
    May 2025
46. LIN SJ, Guo QJ, Liu Q, Ng WT, et al
    International Consensus Guideline on Delineation of the Clinical Target Volumes (CTV) at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version).
    Int J Radiat Oncol Biol Phys. 2025 May 24:S0360-3016(25)00487.
    PubMed     Abstract available
    
    
    
47. LIU Y, Men Y, Bao Y, Ma Z, et al
    Neoadjuvant immunochemoradiotherapy versus chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis of reconstructed individual patient data.
    Int J Radiat Oncol Biol Phys. 2025 May 2:S0360-3016(25)00387.
    PubMed     Abstract available
    
    
    
48. KUIJER KM, Smits HJG, Doornaert PAH, Niu K, et al
    Comparable Performance Between Automatic and Manual Laryngeal and Hypopharyngeal Gross Tumor Volume Delineations Validated With Pathology.
    Int J Radiat Oncol Biol Phys. 2025;122:186-193.
    PubMed     Abstract available
    
    
    April 2025
49. MEHANNA H, Abou-Foul AK, Henson C, Kristunas C, et al
    Accuracy and Prognosis of Extranodal Extension on Radiologic Imaging in Human Papillomavirus-Mediated Oropharyngeal Cancer: a Head and Neck Cancer International Group (HNCIG) real-world study.
    Int J Radiat Oncol Biol Phys. 2025 Apr 24:S0360-3016(25)00370.
    PubMed     Abstract available
    
    
    
50. HUANG Z, Li Y, Wu W, Wu L, et al
    Plasma Epstein-Barr virus DNA Temporal Clearance Pattern During Induction-concurrent (Chemo)radiotherapy for Risk Stratification in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025 Apr 7:S0360-3016(25)00349.
    PubMed     Abstract available
    
    
    
51. MCBRIDE SM
    Oligometastatic Head and Neck Squamous Cell Carcinoma: Is SABR the Solution?
    Int J Radiat Oncol Biol Phys. 2025;121:1207-1208.
    PubMed    
    
    
    March 2025
52. SHI JJ, Meduri K, Liao CY, Moon D, et al
    Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study.
    Int J Radiat Oncol Biol Phys. 2025 Mar 29:S0360-3016(25)00313.
    PubMed     Abstract available
    
    
    
53. ENDE TVD, Kuijper SC, Widaatalla Y, Noortman WA, et al
    Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma Outcomes.
    Int J Radiat Oncol Biol Phys. 2025;121:963-974.
    PubMed     Abstract available
    
    
    
54. BROOKS FMD, Glenn MC, Hernandez V, Saez J, et al
    Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?
    Int J Radiat Oncol Biol Phys. 2025;121:811-821.
    PubMed     Abstract available
    
    
    
55. MORSE RT, Nelson TJ, Liu HC, Sangchan P, et al
    Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk.
    Int J Radiat Oncol Biol Phys. 2025;121:684-692.
    PubMed     Abstract available
    
    
    February 2025
56. GARRIDO-HERNANDEZ G, Ytre-Hauge KS, Winter RM, Danielsen S, et al
    In silico interim adaptation of proton therapy in head and neck cancer by simultaneous dose and linear energy transfer escalation.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00154.
    PubMed     Abstract available
    
    
    
57. YANG L, Liu X, Li Z, Li Z, et al
    Multimodal Image Confidence: A Novel Method for Tumor and Organ Boundary Representation.
    Int J Radiat Oncol Biol Phys. 2025;121:558-569.
    PubMed     Abstract available
    
    
    
58. SANTOS M, Oliveira E Silva LF, Kohler HF, Curioni O, et al
    Erratum to: Santos M, Oliveira e Silva LF, Kohler HF, et al. Health-Related Quality of Life Outcomes in Head and Neck Cancer: Results From a Prospective, Real-World Data Study With Brazilian Patients Treated With Intensity Modulated Radiation Therapy,
    Int J Radiat Oncol Biol Phys. 2025;121:573.
    PubMed    
    
    
    January 2025
59. NAGLER F, Vorbach S, Mohamed AA, Thaqi S, et al
    Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
    Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771.
    PubMed     Abstract available
    
    
    
60. DAMEN PJJ, Peters M, Hobbs B, Chen Y, et al
    Defining the optimal radiation-induced lymphopenia metric to discern its survival impact in esophageal cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jan 2:S0360-3016(24)03770.
    PubMed     Abstract available
    
    
    
61. SANGUINETI G, D'Urso P, Bottero M, Farneti A, et al
    Stereotactic Radiation Therapy in 3 Fractions for T1 Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2025;121:145-152.
    PubMed     Abstract available
    
    
    
62. MENG W, Li L, Hao Y, Tang M, et al
    NAD+ Metabolism Reprogramming Mediates Irradiation-Induced Immunosuppressive Polarization of Macrophages.
    Int J Radiat Oncol Biol Phys. 2025;121:176-190.
    PubMed     Abstract available
    
    
    
63. RAJENDRAN P, Chen Y, Qiu L, Niedermayr T, et al
    Autodelineation of Treatment Target Volume for Radiation Therapy Using Large Language Model-Aided Multimodal Learning.
    Int J Radiat Oncol Biol Phys. 2025;121:230-240.
    PubMed     Abstract available
    
    
    
64. NG WT, Huang SH, Henson C, Bakst RL, et al
    Looking Forward and Looking Back: Cutting-Edge Advances and Long-Standing Controversies in Head and Neck Cancer Management.
    Int J Radiat Oncol Biol Phys. 2025;121:1-7.
    PubMed    
    
    
    December 2024
65. YANG YX, Yang X, Jiang XB, Lin L, et al
    Artificial Intelligence-Empowered Multistep Integrated Radiation Therapy Workflow for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Dec 19:S0360-3016(24)03670.
    PubMed     Abstract available
    
    
    
66. GUO R, Zhang WW, Lv JW, Lin JY, et al
    Long-term Outcomes Following Individualized Elective Primary Tumor CTV Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated with Intensity-modulated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Dec 17:S0360-3016(24)03727.
    PubMed     Abstract available
    
    
    
67. GUO Q, Huang J, Xiao N, Zhou F, et al
    Long-term outcome in cervical lymph node-positive nasopharyngeal carcinoma following IMRT with one-step cervical nodal CTV delineation by geometric-anatomic expansion from nodal GTV: A double-center experience.
    Int J Radiat Oncol Biol Phys. 2024 Dec 12:S0360-3016(24)03723.
    PubMed     Abstract available
    
    
    
68. GRIPPIN A, Kim A, Liu Y, Copling S, et al
    Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies.
    Int J Radiat Oncol Biol Phys. 2024 Dec 12:S0360-3016(24)03724.
    PubMed     Abstract available
    
    
    
69. RUHLE A
    Stick Your Neck Out: Reirradiate or Not in a Head and Neck Cancer Patient With Extracapsular Extension After Salvage Neck Dissection.
    Int J Radiat Oncol Biol Phys. 2024;120:1205-1206.
    PubMed    
    
    
    November 2024
70. THARIAT J, Bosset M, Falcoz A, Vernerey D, et al
    Survival without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial in Head and Neck Cancer Patients with Oligometastases using Stereotactic Ablative Radiotherapy (SABR)-alone or chemotherapy SABR.
    Int J Radiat Oncol Biol Phys. 2024 Nov 27:S0360-3016(24)03651.
    PubMed     Abstract available
    
    
    
71. LUO X, Wang H, Xu J, Li L, et al
    Generalizable MRI-based Nasopharyngeal Carcinoma Delineation: Bridging Gaps across Multiple Centers and Raters with Active Learning.
    Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03644.
    PubMed     Abstract available
    
    
    
72. WANG L, Wang J, Wang T, Li Y, et al
    The Role of Elective Nodal Irradiation in Treating Clinically Node-Negative Sinonasal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;120:1058-1065.
    PubMed     Abstract available
    
    
    
73. MCDOWELL L, King MT, Hutcheson KA, Ringash J, et al
    A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials.
    Int J Radiat Oncol Biol Phys. 2024;120:805-822.
    PubMed     Abstract available
    
    
    
74. ALEXANDER J, Beatty A
    Association of Patient Portal Messaging with Survival Among Radiation Oncology Patients.
    Int J Radiat Oncol Biol Phys. 2024;120:627-638.
    PubMed     Abstract available
    
    
    
75. VAN RIJN-DEKKER MI, la Bastide-van Gemert S, Stokman MA, Vissink A, et al
    Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production.
    Int J Radiat Oncol Biol Phys. 2024;120:772-782.
    PubMed     Abstract available
    
    
    October 2024
76. ZHANG X, Yan J, Lei Q, Neo J, et al
    A Randomised, Multicentre, Phase II Trial of Camrelizumab with or without Metastasis-directed Stereotactic Body Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Oct 23:S0360-3016(24)03512.
    PubMed     Abstract available
    
    
    
77. JABBOUR SK, Higgins KA, Yom SS, Goodman KA, et al
    Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2024;120:309-314.
    PubMed    
    
    
    
78. LIAN B, Yang Y, Zheng B, Si L, et al
    Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined Analysis.
    Int J Radiat Oncol Biol Phys. 2024;120:528-536.
    PubMed     Abstract available
    
    
    September 2024
79. CAI G, Wang K, Zhao J, Huang B, et al
    Predictive value of changes in basal myocardial (18)F-fluorodeoxyglucose uptake for cardiotoxicity in locally advanced esophageal cancer patients receiving definitive radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Sep 20:S0360-3016(24)03403.
    PubMed     Abstract available
    
    
    
80. CHARTERS E, Davies S, Sharman AR, Milross C, et al
    Keeping Swallowing on Track During Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:29-32.
    PubMed    
    
    
    
81. JACOMINA LE, Moreno AC
    Management of Patients With Early-Stage Oropharyngeal Cancer With Clinically Positive Retropharyngeal Lymph Nodes.
    Int J Radiat Oncol Biol Phys. 2024;120:13-14.
    PubMed    
    
    
    
82. WOODY NM
    Spare the Knife When Retropharyngeal Lymph Nodes Are Present in Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:13.
    PubMed    
    
    
    August 2024
83. CHU H, de Vette SPM, Neh H, Sijtsema NM, et al
    3D deep learning Normal Tissue Complication Probability model to predict late xerostomia in head and neck cancer patients.
    Int J Radiat Oncol Biol Phys. 2024 Aug 13:S0360-3016(24)03172.
    PubMed     Abstract available
    
    
    
84. LIN C, Stevens M
    Mandatory Organ Preservation: Adenoid Cystic Carcinoma of the Trachea.
    Int J Radiat Oncol Biol Phys. 2024;119:1334-1335.
    PubMed    
    
    
    
85. DOU S, Zhu G
    Adenoid Cystic Carcinoma in the Trachea: When Surgery is Not Feasible.
    Int J Radiat Oncol Biol Phys. 2024;119:1333-1334.
    PubMed    
    
    
    
86. XING TD, Corry J
    A Rare Cancer Arising in an Uncommon Site: Treatment of Adenoid Cystic Carcinoma of the Trachea.
    Int J Radiat Oncol Biol Phys. 2024;119:1331-1332.
    PubMed    
    
    
    
87. HOSSEINIAN S, Hemmati M, Dede C, Salzillo TC, et al
    Cluster-Based Toxicity Estimation of Osteoradionecrosis Via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification.
    Int J Radiat Oncol Biol Phys. 2024;119:1569-1578.
    PubMed     Abstract available
    
    
    
88. LEAVITT RJ, Almeida A, Grilj V, Montay-Gruel P, et al
    Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;119:1493-1505.
    PubMed     Abstract available
    
    
    
89. ARISTOPHANOUS M, Aliotta E, Lichtenwalner P, Abraham S, et al
    Clinical Experience With an Offline Adaptive Radiation Therapy Head and Neck Program: Dosimetric Benefits and Opportunities for Patient Selection.
    Int J Radiat Oncol Biol Phys. 2024;119:1557-1568.
    PubMed     Abstract available
    
    
    July 2024
90. NORONHA V, Patil V, Menon N, Singh A, et al
    Long term update of a phase 3 randomized study comparing once-a-week versus once-every-3-weeks cisplatin along with radiation in head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jul 27:S0360-3016(24)03139.
    PubMed     Abstract available
    
    
    
91. SHER DJ, Avkshtol V, Moon D, Vo D, et al
    Stereotactic ablative radiotherapy for T1-2 glottic larynx cancer: mature results from the phase II LT-SABR trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 20:S0360-3016(24)02972.
    PubMed     Abstract available
    
    
    
92. LI JS, Blanchard P, Wong CHL, Ahn YC, et al
    International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Jul 13:S0360-3016(24)02954.
    PubMed     Abstract available
    
    
    
93. LI W, Zhao D, Zeng G, Chen Z, et al
    Evaluating Virtual Contrast-enhanced MRI (VCE-MRI) in Nasopharyngeal Carcinoma Radiotherapy: A Retrospective Analysis for Primary Gross Tumor Delineation.
    Int J Radiat Oncol Biol Phys. 2024 Jul 2:S0360-3016(24)00750.
    PubMed     Abstract available
    
    
    
94. KATADA C, Yokoyama T, Watanabe A, Hara H, et al
    Optimizing Organ Preservation Strategies through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results from the CROC Multi-Institutional Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 2:S0360-3016(24)00752.
    PubMed     Abstract available
    
    
    
95. MORSE RT, Mell LK
    Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air.
    Int J Radiat Oncol Biol Phys. 2024;119:783-785.
    PubMed    
    
    
    
96. WILKE C, Henson C, Huang SH, Bakst RL, et al
    Optimizing Therapy: The Art and Science of Modern Head and Neck Radiation.
    Int J Radiat Oncol Biol Phys. 2024;119:709-715.
    PubMed    
    
    
    
97. LI M, Sun H, Yang W, Luo J, et al
    A Phase 1b Clinical Trial of Neoadjuvant Radio-immunotherapy for Esophageal Squamous Cell Cancer.
    Int J Radiat Oncol Biol Phys. 2024;119:896-901.
    PubMed     Abstract available
    
    
    June 2024
98. CHEN B, Chen W, Cheng Q, Zhang H, et al
    Comparison of efficacy and safety of combined chemoimmunotherapy with or without radiotherapy for stage IVB esophageal squamous cell carcinoma: a multicenter propensity score matching analysis.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00741.
    PubMed     Abstract available
    
    
    
99. ZHANG Z, Zhang J, Zheng R, Ye J, et al
    A Population-Based Tumor-Volume Model for Head-and-Neck Cancer During Radiotherapy with a Dynamic Oxygenated Compartment.
    Int J Radiat Oncol Biol Phys. 2024 Jun 11:S0360-3016(24)00684.
    PubMed     Abstract available
    
    
    
100. MILGROM SA, van Luijk P, Pino R, Ronckers CM, et al
     Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review.
     Int J Radiat Oncol Biol Phys. 2024;119:467-481.
     PubMed     Abstract available
     
     
     May 2024
101. CHU Y, Zhu C, Hobbs BP, Chen Y, et al
     Personalized Composite Dosimetric Score-Based Machine Learning Model of Severe Radiation-Induced Lymphopenia among Esophageal Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00668.
     PubMed     Abstract available
     
     
     
102. MCVORRAN S, Naghavi A, Schaner P
     Putting the Brakes on Xerostomia in Oropharyngeal Cancer: Can Brachytherapy Be the Key?
     Int J Radiat Oncol Biol Phys. 2024;119:302-303.
     PubMed    
     
     
     April 2024
103. SMITH J, Margalit D, Golledge J, Nastasi D, et al
     Carotid Artery Stenosis and Ischemic Stroke in Patients with Head and Neck Cancer Treated with Radiotherapy: A Critical Review.
     Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00474.
     PubMed     Abstract available
     
     
     
104. HIROSE K, Sato M
     Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients.
     Int J Radiat Oncol Biol Phys. 2024 Apr 3:S0360-3016(24)00466.
     PubMed     Abstract available
     
     
     
105. HOMMA A, Mikami M, Matsuura K, Onimaru R, et al
     Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients wi
     Int J Radiat Oncol Biol Phys. 2024;118:1271-1281.
     PubMed     Abstract available
     
     
     
106. BUDRUKKAR A, Murthy V, Kashid S, Swain M, et al
     Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial.
     Int J Radiat Oncol Biol Phys. 2024;118:1541-1551.
     PubMed     Abstract available
     
     
     March 2024
107. YOUSSEF I, Mohamed N, Kallini D, Zakeri K, et al
     An Analysis of PET Maximum SUV Among Head and Neck Cancer Patients Receiving Photon and Proton Radiation.
     Int J Radiat Oncol Biol Phys. 2024 Mar 16:S0360-3016(24)00428.
     PubMed     Abstract available
     
     
     
108. CHEN M, Wang K, Wang J
     Vision Transformer-Based Multilabel Survival Prediction for Oropharynx Cancer After Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2024;118:1123-1134.
     PubMed     Abstract available
     
     
     
109. DENG J, Dietrich MS, Aulino JM, Sinard RJ, et al
     Longitudinal Pattern of Lymphedema and Fibrosis in Patients With Oral Cavity or Oropharyngeal Cancer: A Prospective Study.
     Int J Radiat Oncol Biol Phys. 2024;118:1029-1040.
     PubMed     Abstract available
     
     
     
110. MCDOWELL L, Gough K, Fua T, Coleman A, et al
     A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer.
     Int J Radiat Oncol Biol Phys. 2024;118:1018-1028.
     PubMed     Abstract available
     
     
     
111. MOWERY YM
     Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2024;118:757-758.
     PubMed    
     
     
     
112. SAMUELS M, Falkenius J, Bar-Ad V, Dunst J, et al
     A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors.
     Int J Radiat Oncol Biol Phys. 2024;118:743-756.
     PubMed     Abstract available
     
     
     
113. ZHANG S, Li K, Sun Y, Wan Y, et al
     Deep learning for automatic gross tumor volumes contouring in esophageal cancer based on contrast-enhanced CT images: a multi-institutional study.
     Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00350.
     PubMed     Abstract available
     
     
     February 2024
114. DE BRUYCKER A, De Neve W, Daisne JF, Vercauteren T, et al
     Disease control and late toxicity in Adaptive Dose Painting by Numbers vs. non-adaptive radiotherapy for head and neck cancer: a randomized controlled phase II trial.
     Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00025.
     PubMed     Abstract available
     
     
     
115. ADAM DP, Grudzinski JJ, Marsh IR, Hill PM, et al
     Voxel-level dosimetry for combined Iodine-131 radiopharmaceutical therapy and external beam radiotherapy treatment paradigms of head and neck cancer.
     Int J Radiat Oncol Biol Phys. 2024 Feb 15:S0360-3016(24)00308.
     PubMed     Abstract available
     
     
     
116. BRITTON B, Baker AL, Wolfenden L, Wratten C, et al
     Five-year mortality outcomes for Eating As Treatment (EAT), a health behaviour change intervention to improve nutrition in patients with head and neck cancer: a stepped-wedge, randomised controlled trial.
     Int J Radiat Oncol Biol Phys. 2024 Feb 4:S0360-3016(24)00248.
     PubMed     Abstract available
     
     
     
117. GLASER S
     Nodal Recurrence of Uterine Cancer: A Growing Problem.
     Int J Radiat Oncol Biol Phys. 2024;118:319.
     PubMed    
     
     
     
118. LOUATI S, Wozny AS, Malesys C, Daguenet E, et al
     Differential Formation of Stress Granules in Radiosensitive and Radioresistant Head and Neck Squamous Cell Carcinoma Cells.
     Int J Radiat Oncol Biol Phys. 2024;118:485-497.
     PubMed     Abstract available
     
     
     January 2024
119. HUISKES M, Kong W, Oud M, Crama K, et al
     Validation of Fully Automated Robust Multicriterial Treatment Planning for Head and Neck Cancer IMPT.
     Int J Radiat Oncol Biol Phys. 2024 Jan 27:S0360-3016(23)08308.
     PubMed     Abstract available
     
     
     
120. HAHN E, Huang SH
     Leveraging the Potential of Induction Therapy in Human Papillomavirus-Mediated Oropharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2024;118:179-181.
     PubMed    
     
     
     
121. LESTER SC, Moon DH, Patel SH, Awan MJ, et al
     Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2024;118:165-168.
     PubMed    
     
     
     
122. XU T, Shen C, Zhou X, Zhu L, et al
     Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IC
     Int J Radiat Oncol Biol Phys. 2024;118:169-178.
     PubMed     Abstract available
     
     
     
123. MERCADANTE V, Hamad AA, McCaul J, Nutting C, et al
     Salivary Electrostimulation in the Treatment of Radiation Therapy-Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial.
     Int J Radiat Oncol Biol Phys. 2024;118:142-153.
     PubMed     Abstract available
     
     
     December 2023
124. HANNA GJ, Chang SS, Siddiqui F, Bain PA, et al
     Imaging and Biomarker Surveillance for Head and Neck Squamous cell carcinoma: A Systematic Review and Appropriate Use Criteria Document.
     Int J Radiat Oncol Biol Phys. 2023 Dec 31:S0360-3016(23)08258.
     PubMed     Abstract available
     
     
     
125. DUAN Y, Wang J, Wu P, Chen H, et al
     AS-NeSt: a Novel 3D Deep Learning Model for Radiotherapy Dose Distribution Prediction on Esophageal Cancer Treatment with Multiple Prescriptions.
     Int J Radiat Oncol Biol Phys. 2023 Dec 28:S0360-3016(23)08239.
     PubMed     Abstract available
     
     
     
126. ODHIAMBO DA, Pittman AN, Rickard AG, Castillo RJ, et al
     Preclinical Evaluation of the ATR inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08244.
     PubMed     Abstract available
     
     
     
127. THOMSON PD, Slevin PN, Baines H, Betts G, et al
     Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD).
     Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08184.
     PubMed     Abstract available
     
     
     
128. KODAIRA T, Kagami Y, Machida R, Shikama N, et al
     Long-Term Follow-up of a Randomized Controlled Trial on Accelerated Radiation Therapy Versus Standard Fractionated Radiation Therapy for Early Glottic Cancer (JCOG0701A3).
     Int J Radiat Oncol Biol Phys. 2023;117:1118-1124.
     PubMed     Abstract available
     
     
     
129. KYAW JYA, Rendall A, Gillespie EF, Roques T, et al
     Systematic Review and Meta-analysis of the Association Between Radiation Therapy Treatment Volume and Patient Outcomes.
     Int J Radiat Oncol Biol Phys. 2023;117:1063-1086.
     PubMed     Abstract available
     
     
     November 2023
130. HAHN E, Ng WT
     Small Changes, Big Impact: Excitement and Caution in Dose and Volume Reduction for Nasopharyngeal Carcinoma Radiation Therapy After Induction Chemotherapy.
     Int J Radiat Oncol Biol Phys. 2023;117:925-927.
     PubMed    
     
     
     
131. VASQUEZ OSORIO E, Abravan A, Green A, van Herk M, et al
     Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem.
     Int J Radiat Oncol Biol Phys. 2023;117:903-913.
     PubMed     Abstract available
     
     
     
132. YANG Y, Feng T, Fan X, Wang C, et al
     Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2023;117:979-993.
     PubMed     Abstract available
     
     
     
133. KIM K, Ahn YC, Oh D, Noh JM, et al
     Can Definitive Radiation Therapy Substitute Surgical Resection in Locally Advanced T3 or T4 Sinonasal Squamous Cell Carcinoma?
     Int J Radiat Oncol Biol Phys. 2023;117:893-902.
     PubMed     Abstract available
     
     
     
134. HENG J, Li Z, Liu L, Zheng Z, et al
     Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2023;117:966-978.
     PubMed     Abstract available
     
     
     
135. GAO T, Yang Y, Zhang Z, Yang Y, et al
     A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial.
     Int J Radiat Oncol Biol Phys. 2023;117:809-820.
     PubMed     Abstract available
     
     
     
136. RAZAVIAN NB, D'Agostino RB Jr, Shenker RF, Hughes RT, et al
     Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
     Int J Radiat Oncol Biol Phys. 2023;117:652-663.
     PubMed     Abstract available
     
     
     October 2023
137. RUHLE A, Weymann M, Behrens M, Marschner S, et al
     A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.
     Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08025.
     PubMed     Abstract available
     
     
     
138. RINGASH J, Dunphy C, Avery L, Chahin R, et al
     Efficacy of the rehabilitation planning consult for survivors of head and neck cancer: A phase II randomized controlled trial.
     Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07957.
     PubMed     Abstract available
     
     
     
139. DUPERE JM, Lucido JJ, Breen WG, Mahajan A, et al
     Pencil beam scanning proton therapy for pregnant patients with brain and head and neck cancers.
     Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07953.
     PubMed     Abstract available
     
     
     
140. MA TM, Wong DJ, Chai-Ho W, Mendelsohn A, et al
     High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.
     Int J Radiat Oncol Biol Phys. 2023;117:348-354.
     PubMed    
     
     
     
141. GARDEN AS, Harris J, Eisbruch A, Chao KSC, et al
     Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.
     Int J Radiat Oncol Biol Phys. 2023;117:333-340.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum